Bank of America Has Lowered Expectations for MetLife (NYSE:MET) Stock Price

MetLife (NYSE:MET) had its price objective decreased by Bank of America from $103.00 to $99.00 in a note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the financial services provider’s stock. Bank of America‘s target price suggests a potential upside of 27.66% from the stock’s previous close.

Other analysts have also recently issued reports about the company. Mizuho reduced their target price on MetLife from $100.00 to $93.00 and set an “outperform” rating on the stock in a report on Monday. Weiss Ratings cut MetLife from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, March 9th. UBS Group increased their price target on MetLife from $98.00 to $102.00 and gave the stock a “buy” rating in a report on Thursday, April 9th. Morgan Stanley cut their price target on MetLife from $101.00 to $93.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. Finally, TD Cowen cut their price target on MetLife from $91.00 to $88.00 and set a “buy” rating on the stock in a report on Wednesday, March 11th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $93.38.

MetLife Stock Performance

Shares of MET stock opened at $77.55 on Tuesday. The business’s 50 day simple moving average is $73.07 and its 200 day simple moving average is $76.88. MetLife has a one year low of $67.33 and a one year high of $83.85. The stock has a market capitalization of $50.57 billion, a PE ratio of 16.50, a PEG ratio of 0.68 and a beta of 0.74. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.20 and a quick ratio of 0.20.

MetLife (NYSE:MET) last announced its earnings results on Wednesday, February 4th. The financial services provider reported $2.49 EPS for the quarter, beating the consensus estimate of $2.34 by $0.15. MetLife had a return on equity of 21.81% and a net margin of 4.38%.The business had revenue of $52.44 billion for the quarter, compared to analysts’ expectations of $31.43 billion. During the same period in the prior year, the business posted $2.08 earnings per share. The firm’s revenue was up 27.6% on a year-over-year basis. As a group, research analysts forecast that MetLife will post 9.65 earnings per share for the current year.

Hedge Funds Weigh In On MetLife

A number of large investors have recently modified their holdings of MET. Activest Wealth Management lifted its holdings in shares of MetLife by 205.8% in the 4th quarter. Activest Wealth Management now owns 315 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 212 shares in the last quarter. Vermillion & White Wealth Management Group LLC lifted its holdings in shares of MetLife by 790.0% in the 3rd quarter. Vermillion & White Wealth Management Group LLC now owns 356 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 316 shares in the last quarter. Sound Income Strategies LLC lifted its holdings in shares of MetLife by 58.9% in the 4th quarter. Sound Income Strategies LLC now owns 383 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 142 shares in the last quarter. Garton & Associates Financial Advisors LLC bought a new position in shares of MetLife in the 4th quarter worth $30,000. Finally, Gunpowder Capital Management LLC dba Oliver Wealth Management bought a new position in shares of MetLife in the 4th quarter worth $31,000. 94.99% of the stock is currently owned by institutional investors.

More MetLife News

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife told shareholders to reject a mini‑tender offer from Potemkin Limited — the company framed the unsolicited $44.20 bid as opportunistic and well below market, signaling active management protection of shareholder value. MetLife Recommends Shareholders Reject “Mini‑Tender” Offer by Potemkin Limited
• Positive Sentiment: Concert bookings at MetLife Stadium (e.g., Usher & Chris Brown two‑night event) keep venue utilization and non‑insurance revenue opportunities visible to investors. Usher and Chris Brown bring the ‘R&B Tour’ to MetLife for two‑night event
• Positive Sentiment: MetLife Foundation awarded over $6.5M globally, reinforcing ESG/PR initiatives that can support brand and stakeholder relations. MetLife Foundation Awards Over $6.5 Million Globally to Address Essential Community Needs
• Neutral Sentiment: MetLife Stadium is being temporarily rebranded for the 2026 FIFA World Cup (New York‑New Jersey Stadium), increasing global visibility but with unclear direct financial impact on MetLife the insurer. MetLife Stadium temporarily changes its name for World Cup
• Negative Sentiment: Broad negative press about planned NJ Transit fare surges to MetLife Stadium for World Cup events (reports of $80–$100+ one‑way fares) has drawn political pushback from leaders and could create reputational and logistical headaches for stadium events. That controversy can translate into headline risk for MetLife’s stadium association. Trumpflation hits the World Cup: Fans face $80–$100 transit fares on top of $4,000‑plus tickets
• Negative Sentiment: Political leaders including Chuck Schumer and Kathy Hochul publicly criticized high train fares and urged that transport costs be covered, amplifying the negative publicity tied to World Cup logistics at MetLife Stadium. Chuck Schumer, Kathy Hochul Slam FIFA For $100 Train Tickets To MetLife Stadium, Urge Covering Transport For Fans Amid ‘$11 Billion Windfall’
• Negative Sentiment: Bank of America trimmed its price target on MET from $103 to $99 (still a Buy rating), which can exert near‑term selling pressure despite the remaining upside the analyst sees. MetLife (NYSE:MET) Price Target Cut to $99.00 by Analysts at Bank of America

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.